BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30783853)

  • 1. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
    Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
    Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
    Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
    Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review of phyllodes tumours of the breast: A single institution experience.
    Ganesh V; Drost L; Lee J; Wan BA; Zhang L; Rakovitch E; Vesprini D; Slodkowska E; Zeng KL; Sousa P; Yee C; Lam H; Chow E
    Breast; 2018 Apr; 38():52-57. PubMed ID: 29232600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Outcome in Mammary Phyllodes Tumors: Relevance of Clinicopathological Features.
    Li J; Tsang JY; Chen C; Chan SK; Cheung SY; Wu C; Kwong A; Hu J; Hu H; Zhou D; Tse GM
    Ann Surg Oncol; 2019 Sep; 26(9):2747-2758. PubMed ID: 31111353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
    Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
    Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
    Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
    Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.
    Barrio AV; Clark BD; Goldberg JI; Hoque LW; Bernik SF; Flynn LW; Susnik B; Giri D; Polo K; Patil S; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2961-70. PubMed ID: 17562113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast.
    Abdalla HM; Sakr MA
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):125-33. PubMed ID: 17496937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast.
    Wang H; Wang X; Wang CF
    Asian Pac J Cancer Prev; 2014; 15(24):10791-5. PubMed ID: 25605178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the extent of surgical resection important in patient outcome in benign and borderline phyllodes tumors of the breast?
    Sevinç Aİ; Aksoy SÖ; Güray Durak M; Balcı P
    Turk J Med Sci; 2018 Feb; 48(1):28-33. PubMed ID: 29479947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of malignant and borderline phyllodes tumors of the breast: our experience.
    Zervoudis S; Xepapadakis G; Psarros N; Bothou A; Tsikouras P; Galazios G; Kontogianni P; Papazian M; Navrozoglou I; Iatrakis G; Paschopoulos M
    J BUON; 2019; 24(4):1521-1525. PubMed ID: 31646802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
    Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
    Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyllodes tumor of the breast.
    Belkacémi Y; Bousquet G; Marsiglia H; Ray-Coquard I; Magné N; Malard Y; Lacroix M; Gutierrez C; Senkus E; Christie D; Drumea K; Lagneau E; Kadish SP; Scandolaro L; Azria D; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):492-500. PubMed ID: 17931796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Wide Should Margins Be for Phyllodes Tumors of the Breast?
    Tremblay-LeMay R; Hogue JC; Provencher L; Poirier B; Poirier É; Laberge S; Diorio C; Desbiens C
    Breast J; 2017 May; 23(3):315-322. PubMed ID: 27901301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of phyllodes breast tumors.
    Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
    Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent phyllodes tumours of the breast: pathological features and clinical implications.
    Tan EY; Tan PH; Yong WS; Wong HB; Ho GH; Yeo AW; Wong CY
    ANZ J Surg; 2006 Jun; 76(6):476-80. PubMed ID: 16768772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy.
    Lin J; Lin KJ; Wang YF; Huang LH; Chen SL; Chen DR
    BMC Cancer; 2020 May; 20(1):451. PubMed ID: 32434493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.